Economic evaluation of highly purified human menotropin or recombinant follicle-stimulating hormone for controlled ovarian stimulation in high-responder patients: analysis of the Menopur in Gonadotropin-releasing Hormone Antagonist Single Embryo Transfer-High Responder (MEGASET-HR) trial.
F S Rep
; 1(3): 257-263, 2020 Dec.
Article
in En
| MEDLINE
| ID: mdl-34223253
Full text:
1
Database:
MEDLINE
Type of study:
Clinical_trials
/
Health_economic_evaluation
/
Prognostic_studies
Language:
En
Journal:
F S Rep
Year:
2020
Type:
Article